Digital Turbine
APPS
Tempus AI
TEM
Doximity
DOCS
4
Palantir
PLTR
5
monday.com
MNDY
US Stock MarketDetailed Quotes
KRON Kronos Bio
- 0.949
- +0.009+0.94%
Close Mar 17 16:00 ET
- 0.949
- 0.0000.00%
Post 20:01 ET
57.25MMarket Cap-0.66P/E (TTM)
0.959High0.912Low76.46KVolume0.950Open0.940Pre Close72.42KTurnover0.18%Turnover RatioLossP/E (Static)60.34MShares1.60052wk High0.52P/B40.59MFloat Cap0.69052wk Low--Dividend TTM42.78MShs Float39.605Historical High--Div YieldTTM4.99%Amplitude0.690Historical Low0.947Avg Price1Lot Size
Kronos Bio News
Kronos Bio Insider Ups Holding By 36% During Year
We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully
Kronos Bio, Genentech to Terminate Research Partnership; Shares Down Pre-Bell
Express News | Kronos Bio Inc - Enters Transition Agreement With Genentech
Kronos Bio Announces Leadership Change With Deborah Knobelman Appointed as President and Interim CEO
Kronos Bio: Bischofberger Will Remain on Board and Continue to Be Available as Adviser >KRON
Press Release: Kronos Bio Announces CEO Transition and Reduction in Force
Kronos Bio Restructures Workforce and Leadership
On November 22, Kronos Bio Board Approved Approximately 83% Reduction In Its Workforce; Norbert Bischofberger Resigns As President And CEO, Effective December 3, 2024 - Filing
Express News | Kronos Bio Inc - CFO Deborah Knobelman Appointed President and Interim CEO
Express News | Kronos Bio Inc -in Connection With Reduction in Workforce, Co Expects to Incur Charge of Approximately $3.7 Mln
Express News | Kronos Bio Inc - Norberg Bischofberger Resigns as President and CEO
Express News | Kronos Bio - Approves 83% Workforce Reduction as Part of a Strategic Resource Allocation and Cost Containment Plan
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Kronos Bio Highlights Preclinical Data That Show P300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024
Kronos Bio GAAP EPS of -$0.23
TD Cowen Maintains Kronos Bio(KRON.US) With Hold Rating
Piper Sandler Maintains Kronos Bio(KRON.US) With Hold Rating, Maintains Target Price $1
Kronos Bio Cut to Neutral From Overweight by Piper Sandler
TD Cowen Downgrades Kronos Bio(KRON.US) to Hold Rating
Trending Stocks
AI application software AI application software
AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc. AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc.
Unlock Now
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
[2025.2] How should NVIDIA's performance be viewed? The key indicator to watch for short-term stock prices is this.
NVIDIA has been one of the best-performing Technology giants in the US stock market over the past two years, and since 2024, its stock price has experienced sig
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th